{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:19:49Z","timestamp":1786119589641,"version":"build-2736575974"},"reference-count":29,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,3,13]]},"DOI":"10.1097\/qad.0b013e32834404a1","type":"journal-article","created":{"date-parts":[[2011,1,20]],"date-time":"2011-01-20T00:57:59Z","timestamp":1295485079000},"page":"651-657","source":"Crossref","is-referenced-by-count":29,"title":["N-terminal-proB-type natriuretic peptide predicts cardiovascular disease events in HIV-infected patients"],"prefix":"10.1097","volume":"25","author":[{"given":"Daniel A","family":"Duprez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacqueline","family":"Neuhaus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Russell","family":"Tracy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lewis H","family":"Kuller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven G","family":"Deeks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chloe","family":"Orkin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Albrecht","family":"Stoehr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian J","family":"Woolley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James D","family":"Neaton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-14-20210130","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1097\/QAI.0b013e318134257a","article-title":"HIV-infected adults with CD4 cell count greater than 500 cells\/mm3 on long-term combination antiretroviral therapy reach same mortality rates as the general population","volume":"46","author":"Lewden","year":"2007","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R2-14-20210130","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1086\/505147","article-title":"The survival benefits of AIDS treatment of the United States","volume":"194","author":"Walensky","year":"2006","journal-title":"J Infect Dis"},{"key":"R3-14-20210130","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1086\/518285","article-title":"Ischemic heart disease in HIV-infected and HIV-uninfected individuals: a population-based cohort study","volume":"44","author":"Obel","year":"2007","journal-title":"Clin Infect Dis"},{"key":"R4-14-20210130","first-page":"1074","article-title":"Increased acute myocardial infarction rates and cardiovascular risk factors among patients with human immunodeficiency virus disease","volume":"45","author":"Triant","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"R5-14-20210130","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1161\/CIR.0b013e3181d2c863","article-title":"Assessing risk for cardiovascular disease in patients with human immunodeficiency virus. Why it matters","volume":"121","author":"Sax","year":"2010","journal-title":"Circulation"},{"key":"R6-14-20210130","doi-asserted-by":"crossref","first-page":"e41","DOI":"10.1161\/CIRCULATIONAHA.107.189626","article-title":"Screening and assessment of coronary heart disease in HIV-infected patients","volume":"118","author":"Hsue","year":"2008","journal-title":"Circulation"},{"key":"R8-14-20210130","doi-asserted-by":"crossref","first-page":"e203","DOI":"10.1371\/journal.pmed.0050203","article-title":"INSIGHT SMART Study Group. Inflammatory and coagulation biomarkers and mortality in patients with HIV infection","volume":"5","author":"Kuller","year":"2008","journal-title":"PLoS Med"},{"key":"R9-14-20210130","doi-asserted-by":"crossref","first-page":"2357","DOI":"10.1016\/j.jacc.2007.09.021","article-title":"Natriuretic peptides","volume":"50","author":"Daniels","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"R10-14-20210130","first-page":"e391","article-title":"2009 Focused update incorporated into the ACC\/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults A Report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines Developed in Collaboration With the International Society for Heart and Lung Transplantation","volume":"119","author":"Hunt","year":"2009","journal-title":"Circulation"},{"key":"R11-14-20210130","doi-asserted-by":"crossref","first-page":"e95","DOI":"10.1161\/CIRCULATIONAHA.107.185266","article-title":"National Academy of Clinical Biochemistry and IFCC Committee for Standardization of Markers of Cardiac Damage Laboratory Medicine Practice Guidelines: analytical issues for biomarkers of heart failure","volume":"116","author":"Apple","year":"2007","journal-title":"Circulation"},{"key":"R12-14-20210130","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1097\/MCA.0b013e3283292ac6","article-title":"B-type natriuretic peptide: a strong predictor of early and late mortality in patients with acute chest pain without ST-segment elevation in the emergency department","volume":"20","author":"Bassan","year":"2009","journal-title":"Coron Artery Dis"},{"key":"R13-14-20210130","doi-asserted-by":"crossref","first-page":"2177","DOI":"10.1161\/CIRCULATIONAHA.109.884866","article-title":"B-type natriuretic peptides and cardiovascular risk: systematic review and meta-analysis of 40 prospective studies","volume":"120","author":"Di Angelantonio","year":"2009","journal-title":"Circulation"},{"key":"R15-14-20210130","first-page":"185","article-title":"German Heart Failure Network; Competence Network HIV\/AIDS: MR characterization of cardiac abnormalities in HIV+ individuals with increased BNP levels","volume":"29","author":"Breuckmann","year":"2007","journal-title":"Eur J Med Res"},{"key":"R16-14-20210130","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1111\/j.1468-1293.2007.00531.x","article-title":"Right and left cardiac function in HIV-infected patients investigated using radionuclide ventriculography and brain natriuretic peptide: a 5-year follow-up study","volume":"9","author":"Kristoffersen","year":"2008","journal-title":"HIV Med"},{"key":"R17-14-20210130","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1089\/aid.2009.0038","article-title":"Elevated NT-pro-BNP levels are associated with comorbidities among HIV-infected women","volume":"25","author":"Mansoor","year":"2009","journal-title":"AIDS Res Hum Retroviruses"},{"key":"R18-14-20210130","doi-asserted-by":"crossref","first-page":"289","DOI":"10.7326\/0003-4819-149-5-200809020-00003","article-title":"Risk for opportunistic disease and death after reinitiating continuous antiretroviral therapy in patients with HIV previously receiving episodic therapy: a randomized trial.","volume":"149","author":"Study Group","year":"2008","journal-title":"Ann Intern Med"},{"key":"R19-14-20210130","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1177\/135965350801300215","article-title":"Interruption of antiretroviral therapy and risk of cardiovascular disease in persons with HIV-1 infection: exploratory analyses from the SMART trial","volume":"13","author":"Phillips","year":"2008","journal-title":"Antivir Ther"},{"key":"R20-14-20210130","first-page":"395","article-title":"Dilated cardiomyopathy in two adult human immunodeficiency positive (HIV+) patients possibly related to highly active antiretroviral therapy (HAART)","volume":"10","author":"Breuckmann","year":"2005","journal-title":"Eur J Med Res"},{"key":"R21-14-20210130","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1016\/S0735-1097(02)02059-4","article-title":"Plasma brain natriuretic peptide concentration: impact of age and gender","volume":"40","author":"Redfield","year":"2002","journal-title":"J Am Coll Cardiol"},{"key":"R22-14-20210130","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1161\/CIRCHEARTFAILURE.109.854943","article-title":"Impact of HIV infection on diastolic function and left ventricular mass","volume":"3","author":"Hsue","year":"2010","journal-title":"Circ Heart Fail"},{"key":"R23-14-20210130","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.ejim.2007.01.006","article-title":"Brain natriuretic peptide increases in septic patients without severe sepsis or shock","volume":"18","author":"Nikolaou","year":"2007","journal-title":"Eur J Intern Med"},{"key":"R24-14-20210130","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.yjmcc.2004.01.001","article-title":"Selective upregulation of cardiac brain natriuretic peptide at the transcriptional and translational levels by pro-inflammatory cytokines and by conditioned medium derived from mixed lymphocyte reactions via p38 MAP kinase","volume":"36","author":"Ma","year":"2004","journal-title":"J Mol Cell Cardiol"},{"key":"R25-14-20210130","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1006\/jmcc.2002.2005","article-title":"Transcriptional activation of the BNP gene by lipopolysaccharide is medicated through GATA elements in neonatal rat myocytes","volume":"34","author":"Tomaru Ki","year":"2002","journal-title":"J Mol Cell Cardiol"},{"key":"R26-14-20210130","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1152\/japplphysiol.90442.2008","article-title":"Plasma NT-proBNP increases in response to LPS administration in healthy men","volume":"105","author":"Vila","year":"2008","journal-title":"J Appl Physiol"},{"key":"R27-14-20210130","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1038\/nm1511","article-title":"Microbial translocation is a cause of systemic immune activation in chronic HIV infection","volume":"12","author":"Brenchley","year":"2006","journal-title":"Nature Med"},{"key":"R28-14-20210130","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1111\/j.1538-7836.2006.01916.x","article-title":"Markers of hypercoagulability and inflammation predict mortality in patients with heart failure","volume":"4","author":"Marcucci","year":"2006","journal-title":"J Thromb Haemost"},{"key":"R29-14-20210130","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1097\/QAI.0b013e3181b02e6a","article-title":"Untreated HIV infection and large and small artery elasticity","volume":"52","author":"Baker","year":"2009","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"3A","key":"R30-14-20210130","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.amjcard.2007.11.029","article-title":"Amino-terminal pro\u2013B-type natriuretic peptide testing in renal disease","volume":"101","author":"DeFilippi","year":"2008","journal-title":"Am J Cardiol"},{"key":"R31-14-20210130","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1097\/QAD.0b013e328339fe53","article-title":"Estimated glomerular filtration rate, chronic kidney disease and antiretroviral drug use in HIV-positive patients","volume":"24","author":"Mocroft","year":"2010","journal-title":"AIDS"}],"container-title":["AIDS"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00002030-201103130-00014","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T18:55:44Z","timestamp":1786042544000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00002030-201103130-00014"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,3,13]]},"references-count":29,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2011]]}},"URL":"https:\/\/doi.org\/10.1097\/qad.0b013e32834404a1","relation":{},"ISSN":["0269-9370"],"issn-type":[{"value":"0269-9370","type":"print"}],"subject":[],"published":{"date-parts":[[2011,3,13]]}}}